Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20008390HPVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TVIS20040306HPVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TVIS20055009HPVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TVIS20014247HPVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TVIS20055082HPVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TVIS20068219HPVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TVIS20054822HPVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TVIS20024149HPVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TVIS20031193HPVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TVIS44028685HTLV-1ENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TCGA Plot Options
Drug Information
GeneKCNH7
DrugBank IDDB01162
Drug NameTerazosin
Target IDBE0000699
UniProt IDQ9NS40
Regulation Typeinhibitor
PubMed IDs15098086
CitationsThomas D, Wimmer AB, Wu K, Hammerling BC, Ficker EK, Kuryshev YA, Kiehn J, Katus HA, Schoels W, Karle CA: Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin. Naunyn Schmiedebergs Arch Pharmacol. 2004 May;369(5):462-72. Epub 2004 Apr 20.
GroupsApproved
Direct ClassificationN-arylpiperazines
SMILESCOC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1CCCO1
Pathways
PharmGKBPA451612
ChEMBLCHEMBL611